Schwartz JH - Search Results

1

Characterizing relapse prevention in bipolar disorder with adjunctive ziprasidone: clinical and methodological implications.

Bowden CL, Karayal ON, Schwartz JH, Gundapaneni BK, O'Gorman C. Bowden CL, et al. Among authors: schwartz jh. J Affect Disord. 2013 Jan 10;144(1-2):171-5. doi: 10.1016/j.jad.2012.04.024. Epub 2012 Sep 21. J Affect Disord. 2013. PMID: 22999893 Clinical Trial.

2

Ziprasidone plus a mood stabilizer in subjects with bipolar I disorder: a 6-month, randomized, placebo-controlled, double-blind trial.

Bowden CL, Vieta E, Ice KS, Schwartz JH, Wang PP, Versavel M. Bowden CL, et al. Among authors: schwartz jh. J Clin Psychiatry. 2010 Feb;71(2):130-7. doi: 10.4088/JCP.09m05482yel. Epub 2010 Jan 26. J Clin Psychiatry. 2010. PMID: 20122373 Clinical Trial.

3

Efficacy, long-term safety, and tolerability of ziprasidone in children and adolescents with bipolar disorder.

Findling RL, Cavuş I, Pappadopulos E, Vanderburg DG, Schwartz JH, Gundapaneni BK, DelBello MP. Findling RL, et al. Among authors: schwartz jh. J Child Adolesc Psychopharmacol. 2013 Oct;23(8):545-57. doi: 10.1089/cap.2012.0029. Epub 2013 Oct 10. J Child Adolesc Psychopharmacol. 2013. PMID: 24111980 Free PMC article. Clinical Trial.

4

Ziprasidone in adolescents with schizophrenia: results from a placebo-controlled efficacy and long-term open-extension study.

Findling RL, Cavuş I, Pappadopulos E, Vanderburg DG, Schwartz JH, Gundapaneni BK, DelBello MP. Findling RL, et al. Among authors: schwartz jh. J Child Adolesc Psychopharmacol. 2013 Oct;23(8):531-44. doi: 10.1089/cap.2012.0068. Epub 2013 Oct 10. J Child Adolesc Psychopharmacol. 2013. PMID: 24111983 Free PMC article. Clinical Trial.

5

Tafamidis delays neurological progression comparably across Val30Met and non-Val30Met genotypes in transthyretin familial amyloid polyneuropathy.

Gundapaneni BK, Sultan MB, Keohane DJ, Schwartz JH. Gundapaneni BK, et al. Among authors: schwartz jh. Eur J Neurol. 2018 Mar;25(3):464-468. doi: 10.1111/ene.13510. Epub 2017 Dec 26. Eur J Neurol. 2018. PMID: 29115008 Free PMC article. Clinical Trial.

6

Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy.

Maurer MS, Schwartz JH, Gundapaneni B, Elliott PM, Merlini G, Waddington-Cruz M, Kristen AV, Grogan M, Witteles R, Damy T, Drachman BM, Shah SJ, Hanna M, Judge DP, Barsdorf AI, Huber P, Patterson TA, Riley S, Schumacher J, Stewart M, Sultan MB, Rapezzi C; ATTR-ACT Study Investigators. Maurer MS, et al. Among authors: schwartz jh. N Engl J Med. 2018 Sep 13;379(11):1007-1016. doi: 10.1056/NEJMoa1805689. Epub 2018 Aug 27. N Engl J Med. 2018. PMID: 30145929 Free article. Clinical Trial.

7

Influence of baseline neurologic severity on disease progression and the associated disease-modifying effects of tafamidis in patients with transthyretin amyloid polyneuropathy.

Amass L, Li H, Gundapaneni BK, Schwartz JH, Keohane DJ. Amass L, et al. Among authors: schwartz jh. Orphanet J Rare Dis. 2018 Dec 17;13(1):225. doi: 10.1186/s13023-018-0947-7. Orphanet J Rare Dis. 2018. PMID: 30558645 Free PMC article. Clinical Trial.

8

Early intervention with tafamidis provides long-term (5.5-year) delay of neurologic progression in transthyretin hereditary amyloid polyneuropathy.

Waddington Cruz M, Amass L, Keohane D, Schwartz J, Li H, Gundapaneni B. Waddington Cruz M, et al. Amyloid. 2016 Sep;23(3):178-183. doi: 10.1080/13506129.2016.1207163. Epub 2016 Aug 5. Amyloid. 2016. PMID: 27494299 Free PMC article. Clinical Trial.

9

Tafamidis delays disease progression in patients with early stage transthyretin familial amyloid polyneuropathy: additional supportive analyses from the pivotal trial.

Keohane D, Schwartz J, Gundapaneni B, Stewart M, Amass L. Keohane D, et al. Amyloid. 2017 Mar;24(1):30-36. doi: 10.1080/13506129.2017.1301419. Epub 2017 Apr 10. Amyloid. 2017. PMID: 28393570 Clinical Trial.

10

Design and Rationale of the Phase 3 ATTR-ACT Clinical Trial (Tafamidis in Transthyretin Cardiomyopathy Clinical Trial).

Maurer MS, Elliott P, Merlini G, Shah SJ, Cruz MW, Flynn A, Gundapaneni B, Hahn C, Riley S, Schwartz J, Sultan MB, Rapezzi C; ATTR-ACT Study Investigators. Maurer MS, et al. Circ Heart Fail. 2017 Jun;10(6):e003815. doi: 10.1161/CIRCHEARTFAILURE.116.003815. Circ Heart Fail. 2017. PMID: 28611125 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

372 results

Search Page